Insurance companys have established specialy drug tiers that require coinsurance payments for drugs commonly used for chronic long-term therapys. These coinsurance payments often are in the 30-35% range on drugs that cost up to $6000.00 per month.

The Patients’ Access to Treatments Act of 2012 eliminates coinsurance and limits copays to the amount charged for name brand non-preferred drugs in the providers formularly.